New eye drop shows promise for dry eye sufferers in Late-Stage trial
Symptom relief
Completed
This Phase 3 trial tested SI-614 eye drops, a modified form of sodium hyaluronate, against placebo in 232 adults with dry eye disease. Participants used the drops four times daily for 84 days. The study measured changes in eye surface staining (a sign of damage) and daily symptom…
Phase: PHASE3 • Sponsor: Seikagaku Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC